Comparison between Mankind Pharma IPO and Udayshivakumar Infra IPO.
Mankind Pharma IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Udayshivakumar Infra IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Mankind Pharma IPO is up to ₹4,326.36 Cr whereas the issue size of the Udayshivakumar Infra IPO is up to ₹66.00 Cr. The final issue price of Mankind Pharma IPO is ₹1,080.00 per share and of Udayshivakumar Infra IPO is ₹35.00 per share.
| Mankind Pharma IPO | Udayshivakumar Infra IPO | |
|---|---|---|
| Face Value | ₹1 per share | ₹10 per share |
| Issue Price (Lower) | ₹1,026.00 per share | ₹33.00 per share |
| Issue Price (Upper) | ₹1,080.00 per share | ₹35.00 per share |
| Issue Price (Final) | ₹1,080.00 per share | ₹35.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 13 shares | 428 shares |
| Fresh Issue Size | 0 shares | 1,88,57,142 shares |
| Fresh Issue Size (Amount) | up to ₹0.00 Cr | up to ₹66.00 Cr |
| OFS Issue Size | 4,00,58,844 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹4,326.36 Cr | up to ₹0.00 Cr |
| Issue Size Total | 4,00,58,844 shares | 1,88,57,142 shares |
| Issue Size Total (Amount) | up to ₹4,326.36 Cr | up to ₹66.00 Cr |
Mankind Pharma IPO opens on Apr 25, 2023, while Udayshivakumar Infra IPO opens on Mar 20, 2023. The closing date of Mankind Pharma IPO and Udayshivakumar Infra IPO is Apr 27, 2023, and Mar 23, 2023, respectively.
| Mankind Pharma IPO | Udayshivakumar Infra IPO | |
|---|---|---|
| Anchor Bid Date | Apr 24, 2023 | |
| Issue Open | Apr 25, 2023 | Mar 20, 2023 |
| Issue Close | Apr 27, 2023 | Mar 23, 2023 |
| Basis Of Allotment (Tentative) | May 03, 2023 | Mar 28, 2023 |
| Initiation of Refunds (Tentative) | May 04, 2023 | Mar 29, 2023 |
| Credit of Share (Tentative) | May 05, 2023 | Mar 31, 2023 |
| Listing date (Tentative) | May 09, 2023 | Apr 03, 2023 |
| Anchor Lockin End date 1 | Jun 02, 2023 | |
| Anchor Lockin End date 2 | Aug 01, 2023 |
Mankind Pharma IPO P/E ratio is 32.5, as compared to Udayshivakumar Infra IPO P/E ratio of 9.67.
| Mankind Pharma IPO | Udayshivakumar Infra IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated Consolidated)
| Company Financials (Restated)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 79.00 | 100.00 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 76.50 | 65.9 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 32.5 | 9.67 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹43263.60 Cr. | ₹193.75 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 27.60% | 17.78 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 26.10% | 20.71 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.39 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹33.20 | ₹3.33 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 27.70% | 17.78 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Mankind Pharma IPO Retail Individual Investors (RII) are offered 1,40,20,596 shares while in Udayshivakumar Infra IPO retail investors are offered 1,40,20,596 shares. Qualified Institutional Buyers (QIB) are offered 80,11,769 shares in Mankind Pharma IPO and 18,85,713 shares in Udayshivakumar Infra IPO.
| Mankind Pharma IPO | Udayshivakumar Infra IPO | |
|---|---|---|
| Anchor Investor Reservation | 1,20,17,652 shares | |
| Market Maker Reservation | ||
| QIB | 80,11,769 shares | 18,85,713 shares |
| NII | 60,08,827 shares | 56,57,143 shares |
| RII | 1,40,20,596 shares | 1,13,14,286 shares |
| Employee | ||
| Others | ||
| Total | 4,00,58,844 shares | 1,88,57,142 shares |
Mankind Pharma IPO subscribed 15.32x in total, whereas Udayshivakumar Infra IPO subscribed 32.49x.
| Mankind Pharma IPO | Udayshivakumar Infra IPO | |
|---|---|---|
| QIB (times) | 49.16x | 42.92x |
| NII (times) | 3.80x | 64.08x |
| Big NII (times) | 4.99x | 63.54x |
| Small NII (times) | 1.41x | 65.14x |
| RII (times) | 0.92x | 14.95x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 15.32x | 32.49x |
